Join
Live feed
·
PRReleasevia Quantisnow
NovaBridge Biosciences logo

Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis

ByQuantisnow·Wall Street's wire, on your screen.
NBP· NovaBridge Biosciences
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBP (NovaBridge Biosciences) and more on Quantisnow.